HEALTHWELL FOUNDATION 2025 ANNUAL REPORT PAGE 9 HealthWell fills a crucial financial gap for underinsured Americans by assisting them with copays, premiums, deductibles, and out-of- pocket expenses. In 2025, we offered financial assistance through 59 disease-specific and specialty funds, including multiple funds in oncology and special initiative funds to assist pediatric patients, those facing unaffordable premiums for Affordable Care Act (ACA) Marketplace plans, and patients who needed help affording the cost of transportation to treatment appointments. We launched or reopened 15 funds in 2025, including new funds for: • Bronchiectasis, providing up to $12,000 in medication copayment or insurance premium (Medicare Part B) assistance. • ACA Marketplace plans, providing up to $2,000 in insurance premium assistance to individuals who have obtained health coverage through an ACA marketplace plan. • Parkinson’s disease, providing up to $4,000 in medication copayment or Medicare Part B premium assistance to Medicare patients for prescription drugs and biologics for the treatment of Parkinson’s disease. • Neuroendocrine tumors, providing up to $15,000 in medication copayment or insurance premium assistance to patients for prescription drugs and biologics for the treatment of their disease. HealthWell Reduces Financial Barriers to Care for Underinsured Patients with Chronic or Life-Altering Diseases Funds Open During 2025 • ACA Marketplace Insurance Premium Assistance • Acromegaly • Acute Myeloid Leukemia • Alagille Syndrome Vitamins and Supplements • Amyloidosis • Amyotrophic Lateral Sclerosis • ANCA-Associated Vasculitis, and Granulomatosis with Polyangiitis (formerly Wegeners) • B-Cell Lymphoma — Medicare Access • Blepharitis • Breast Cancer — Medicare Access • Bronchiectasis • Cancer Home Care Services • Cancer-Related Behavioral Health • Cardiomyopathy — Medicare Access • Chronic Lymphocytic Leukemia • Chronic Myeloid Leukemia – Medicare Access • Chronic Obstructive Pulmonary Disease — Medicare Access • Colorectal Carcinoma — Medicare Access • Congenital Sucrase-Isomaltase Deficiency • Cushing’s Disease or Cushing’s Syndrome • Cystic Fibrosis Treatments • Cystic Fibrosis Vitamins and Supplements • Cytomegalovirus Disease — Prevention and Treatment • Dupuytren’s Disease • Emergency/Medical Workers Behavioral Health • General Travel • Giant Cell Arteritis or Temporal Arteritis — Medicare Access • Gout Travel • Hepatitis C • Hypercholesterolemia — Medicare Access • Hyperoxaluria • IgA Nephropathy • Inborn Metabolic or Genetic Bile Acid Deficiency Vitamins and Supplements • Macular Degeneration (Wet and Dry) • Mantle Cell Lymphoma • Metabolic Dysfunction-Associated Steatohepatitis • Multiple Myeloma — Medicare Access • Multiple Sclerosis — Medicare Access • Myelodysplastic Syndromes — Medicare Access • Neurocognitive Disease with Psychosis — Medicare Access • Non-Small Cell Lung Cancer — Medicare Access • Nontuberculous Mycobacterium — Medicare Access • Oncology Caregiver Behavioral Health Fund • Ovarian Cancer — Medicare Access • Pancreatic Cancer — Medicare Access • Parkinson’s Disease — Medicare Access • Pediatric Assistance • Peyronie’s Disease • Porphyrias • Prostate Cancer — Medicare Access • Pulmonary Fibrosis • Pulmonary Hypertension — Medicare Access • Renal Cell Carcinoma — Medicare Access • Schizophrenia — Medicare Access • Small Cell Lung Cancer — Medicare Access • Systemic Sclerosis with Interstitial Lung Disease • Tardive Dyskinesia — Medicare Access • Urticaria • Waldenstrom Macroglobulinemia
View this content as a flipbook by clicking here.